Inflammatory Bowel Diseases 2009
Inflammatory Bowel Diseases 2009
4th Congress of ECCO -
the European Crohn's and Colitis Organisation
February 5th-7th, 2009
CCH Congress Center Hamburg, Germany
Presentations
For the author`s scientific profile at BIOMEDEXPERTS, please click author
Colonic mucosal expression of barrier genes in patients with inflammatory bowel disease before and after first infliximab treatment
Ingrid Arijs1,2, L. Van Lommel2, K. Van Steen4, G. De Hertogh3, R. Quintens2 , G. Van Assche
1, S. Vermeire1, K. Geboes3, Schuit2 and P. Rutgeerts1
1Gastroenterology, 3Morphology and Molecular Pathology, University Hospital Gasthuisberg, Leuven, Belgium; 2Gene Expression Unit, Department of Molecular Cell Biology, Katholieke Universiteit Leuven, Leuven, Belgium; 4Department of Electrical Engineering and Computer Science (Montefiore Institute), University of Liege, Liege, Belgium.
T-cell selective inhibition of gut pro-inflammatory cytokine production by a Ca2+ release-activated Ca2+ channel blocker in inflammatory bowel
Antonio Di Sabatino, Laurens Kruidenier, Laura Rovedatti, Nickolas Leakey, Michael Wilson, Lisa Lione, Charles Knowles, Kevin Lee, Peter McLean, Gino R. Corazza, Thomas T. MacDonald
Clinica Medica I, Fondazione IRCCS Policlinico S. Matteo;Centro per lo Studio e la Cura delle Malattie Infiammatorie Croniche Intestinali, University of Pavia; Centre for Infectious Disease, ICMS, Barts and the London School of Medicine and Dentistry, London, UK; Immuno-Inflammation CEDD, GlaxoSmithKline, UK.
The unmet therapeutic need in IBD: the Japanese perspective
Division of Gastroenterology and Hepatology, Department of Internal Medicine Keio University School of Medicine, Tokyo, Japan
How do anti-inflammatory therapies work? - Back from the bedside to the bench
Charité Campus Benjamin Franklin, Berlin, Germany
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6
Vetrano Stefania, Borroni EM, Bonecchi R1, Correale C, Sarukhan A, Arena V, Fantini M, Roncalli M, Repici A, Mantovani A, Locati M and Danese S
IBD Research Unit, Istituto Clinico Humanitas, Rozzano, Milan; Italy
Changing gut flora: Aetiologic & therapeutic implications
Patricia Lepage1 and Herbert Tilg2
1Biodiversity and Metagenomics, Ecology and Physiology of the GIT INRA – Jouy-en-Josas Research Center
2Department of Medicine, Christian Doppler Research Laboratory for Gut Inflammation, Hall in Tirol/Innsbruck, Austria
Temporal stability of faecal microbiota with IS-pro; a novel method
Matthijs E. Grasman1, A.E. Budding2, C.J.J. Mulder1, C.M.J.E. Vandenbroucke-Grauls2, P.H.M. Savelkoul2, A.A. van Bodegraven1
1Dept. of Gastroenterology and Hepatology, 2Dept. of Medical Microbiology and Infection Control, VU University Medical Centre, Amsterdam, The Netherlands
Role of small bowel endoscopy in the management of patients with IBD:
international ECCO-OMED consensus
Ana Ignjatovic, Arnaud Bourreille, Simon Travis, Jean-Frederic Colombel, Andre Van Gossum
on behalf of the Organisation Mondial d’Endoscopie Digestive (OMED) and the European Crohn’s and Colitis Organisation (ECCO)
Immunomodulators in IBD: Is there a price to pay?
Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium
Thiopurine therapy is associated with a three-fold decrease in the incidence of advanced colorectal neoplasia in IBD patients with longstanding extensive colitis:
the CESAME prospective data
Laurent Beaugerie, Ph Seksik and F. Carrat
for the CESAME Study Group, Saint-Antoine hospital, Paris, France
Stress in IBD:The overlooked villain
Barts and the London Queen Mary`s School of Medicine and Dentistry, London, United Kingdom
Role of TAK1 in Crohn’s disease: a new molecular marker of fibrosis?
Alessia R. Grillo
Padua, Italy
The right use of diagnostics: How not to harm the patient?
Gastroenterology Department, CHU Liège, GIGAresearch, University of Liège
Crohn`s disease : Where it all started and where it`s all going
New York, United States of America
Clinical Course and Cost of Care in Ulcerative Colitis
Markov Chain Analysis of a European Prospective Population-Based Cohort
Selwyn Odes1, H. Vardi2, M. Friger2, P. Munkholm3, D. Esser4, M. Elkjaer3, H. Waters5, E. Langholz6
1Gastroenterology, Soroka Medical Center, Ben Gurion University, Beer Sheva, Israel; 2Epidemiology, Ben Gurion University, Beer Sheva, Israel; 3Gastroenterology, Herlev University Hospital, Copenhagen, Denmark; 4Centocor BV, Leiden, Netherlands; 5Centocor Ortho Biotech Services, Malvern, PA, USA; 6Gastroenterology, Gentofte Hospital, Copenhagen, Denmark
Fistulizing Crohn’s Disease
Chair of Gastroenterology, University of Udine Medical School, Udine, Italy
ECCO Crohn’s Disease Consensus 2008:
paediatric / adolescent disease, pregnancy and psychosomatics
Digestive Diseases Clinical Academic Unit, Barts and the London NHS Trust London, UK
Printer-friendly version
